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Abstract Elite distance runners participated in one of
two studies designed to investigate the eects of mod-
erate altitude training (inspiratory partial pressure of
oxygen »115–125 mmHg) on submaximal, maximal and
supramaximal exercise performance following return to
sea-level. Study 1 (New Mexico, USA) involved 14
subjects who were assigned to a 4-week altitude training
camp (1500–2000 m) whilst 9 performance-matched
subjects continued with an identical training programme
at sea-level (CON). Ten EXP subjects who trained at
1640 m and 19 CON subjects also participated in study 2
(Krugersdorp, South Africa). Selected metabolic and
cardiorespiratory parameters were determined with the
subjects at rest and during exercise 21 days prior to
(PRE) and 10 and 20 days following their return to sea-
level (POST). Whole blood lactate decreased by 23%
(P < 0.05 vs PRE) during submaximal exercise in the
EXP group only after 20 days at sea-level (study 1).
However, the lactate threshold and other measures of
running economy remained unchanged. Similarly, su-
pramaximal performance during a standardised track
session did not change. Study 2 demonstrated that
hypoxia per se did not alter performance. In contrast, in
the EXP group supramaximal running velocity de-
creased by 2% (P < 0.05) after 20 days at sea-level.
Both studies were characterised by a 50% increase in the
frequency of upper respiratory and gastrointestinal tract
infections during the altitude sojourns, and two male
subjects were diagnosed with infectious mononucleosis
following their return to sea-level (study 1). Group mean
plasma glutamine concentrations at rest decreased by
19% or 143 (74) lM (P < 0.001) after 3 weeks at alti-
tude, which may have been implicated in the increased
incidence of infectious illness.
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Introduction
Acclimatisation to a reduced inspiratory partial pressure
of oxygen (PIO2) initiates metabolic and cardiorespira-
tory adaptations that influence oxygen transport and
utilisation. Some adaptations may facilitate endurance
performance, whereas others are less beneficial. Al-
though equivocal, human studies have demonstrated
that either hypobaric or normobaric hypoxia per se is
responsible for increases in blood haemoglobin (Hb)
concentration (Berglund 1992), muscle mitochondrial
volume, capillary supply (Desplanches et al. 1993), aer-
obic enzyme activities and myoglobin concentration
(Terrados et al. 1990), 2,3-diphosphoglycerate (Ma-
irbaurl et al. 1986), rate of free fatty acid mobilisation
(Young et al. 1982) or an elevated blood buering ca-
pacity (Favier et al. 1995). Altitude acclimatisation im-
proves physical performance at altitude (Pugh 1967;
Maher et al. 1974), but the eects on sea-level perfor-
mance are less clear. Since the 1950’s, 64 out of 91
studies on the eects of altitude training on sea-level
endurance performance have been conducted without a
performance-matched control group trained in norm-
oxia, and of the 15 controlled investigations, only 4 have
reported performance-enhancing benefits (Bailey and
Davies 1997).
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Hypobaric hypoxia decreases training intensity, and
this may induce a detraining response (Levine and Stray-
Gundersen 1997), as demonstrated in the elite athlete at
altitudes as low as 610 m above sea-level (Gore et al.
1996). Levine and Stray-Gundersen (1997) demonstrat-
ed the synergistic eects of altitude acclimatisation and
endurance training as a means of potentiating sea-level
endurance performance in a ‘‘live-high, train-low’’ ap-
proach. However, there is evidence which challenges the
benefits of altitude training. Oxygen transport, deter-
mined as a product of blood flow and arterial oxygen
concentration (flow ´ CaO2) is regulated in response to
changes in arterial partial pressure of oxygen (Welch
1987). Wolfel et al. (1996) investigated systemic oxygen
transport at an ambient partial pressure of oxygen (PO2)
of 97 mmHg and established that despite the increase in
CaO2 due to an increased Hb concentration, oxygen
transport was unaected due to a reduction in blood
flow caused by sympathetically mediated local and/or
systemic vasoconstriction. A decrease in muscle perfu-
sion persists following return to sea-level. Using 133Xe it
has been shown that blood flow to the vastus lateralis
muscle decreases by as much as 39% during submaximal
exercise after a 3-month expedition to 8,398 m (Boutel-
lier et al. 1982).
Both in vivo and in vitro evidence suggests that hy-
pobaric hypoxia decreases immunoreactivity, specifically
by suppressing T-cell-mediated immunity (Meehan
1987, 1988). Oxidative damage mediated by free radicals
also increases at altitude (Simon-Schnass 1990; Va-
sankari et al. 1997) which has implications for mem-
brane integrity and energy metabolism. In addition to
the potentially immunosuppressive eects of high-vol-
ume intense physical exercise (Nieman 1996), the addi-
tional stress of a decreased PIO2 may challenge both the
health and fitness of the elite competitor.
Two studies were designed to elucidate the mecha-
nisms that regulate physiological indices of submaximal,
maximal and supramaximal exercise performance fol-
lowing a sojourn to altitude in a homogenous group of
elite distance runners.
Methods
Subjects
Fifty two British National distance runners (800–5,000 m special-
ists) volunteered and gave their informed consent for two altitude
training studies which had been approved by the British Olympic
Association and the British Athletic Federation (Table 1). All
subjects were taking oral iron supplements (200 mg of ferrous
sulphate á day)1).
Two investigations were conducted at the same time of year and
at similar altitudes (1500–2000 m above sea-level, PIO2  115–
125 mmHg). The first study investigated the responses to sub-
maximal [<maximal oxygen uptake ( _V O2max)] and supramaximal
(> _V O2max) exercise following 4 weeks of endurance training at
Albuquerque, New Mexico (1500–2000 m). The second study in-
vestigated responses to maximal and supramaximal exercise fol-
lowing 4 weeks of similar training at Krugersdorp, South Africa
(1640 m).
Study 1: Submaximal laboratory measurements and procedures
Each subject performed two standardised treadmill runs to control
for the eects of habituation on exercise performance. Sixteen male
and seven female subjects subsequently performed a discontinuous
incremental treadmill test in a temperature-controlled laboratory
set at 21  1°C. The test consisted of five incremental stages each
of 4 min in duration and separated by 30 s for the collection of an
earlobe blood sample for the determination of the lactate threshold
(h [La)]B), according to the method of Cheng et al. (1992). Running
velocity (m á s)1) at a fixed whole blood lactate concentration
([La)]B) of 2 and 4 mmol á l
)1 was interpolated by fitting an ex-
ponential equation to each subject’s lactate-velocity curve. Tread-
mill velocity increments were calculated to represent between 70
and 110% of the subjects’ 10-km personal best running times on
the road and ranged between 3.56 and 5.86 m á s)1 for the male
athletes and 3.19 to 5.06 m á s)1 for the females. The subjects were
subsequently assigned to two groups: 14 subjects travelled to an
altitude training camp based at New Mexico (EXPSUB) whilst 9
subjects continued with their normal training programme at sea-
level in the UK (CONSUB). Each subject performed the test 3 weeks
prior to (PRESUB) and 3 weeks following their return from altitude
(POSTSUB).
Study 2 Maximal laboratory measurements and procedures
Twenty two male and seven female subjects (n  29) performed an
incremental treadmill test to exhaustion according to Taylor et al.
(1955) for the determination of _V O2max. This was preceded by a 3-
min recovery walk on the level at 1.39 m á s)1 (REC). Subjects were
Table 1 Anthropometric and dietary data at sea-level. (PRE EXPSUB Pre-altitude experimental submaximal exercise group, PRE
CONSUB pre-altitude control submaximal exercise group, PRE EXPMAX pre-altitude experimental maximal exercise group, PRECONMAX
pre-altitude control maximal exercise group, FVC forced vital capacity, CHO carbohydrate intake, Cal intake daily calorific intake)
New Mexico South Africa
PRE EXPSUB PRE CONSUB PRE EXPMAX PRECONMAX
n 14 9 10 19
Age (years) 24 (4) 25 (4) 22 (4) 24 (2)
Body mass (kg) 62.0 (8.7) 60.9 (6.0) 68.6 (7.3) 64.2 (6.6)
Stature (m) 1.75 (0.11) 1.73 (0.06) 1.79 (0.07) 1.75 (0.08)
FVC (l á min)1) 4.81 (0.99) 4.90 (0.77) 5.40 (0.91) 5.07 (0.71)
Body fat (%) 11.9 (6.0) 11.2 (5.3) 9.1 (3.9) 11.0 (4.9)
CHO (g á kg)1 bwt) 6.6 (1.4) 5.5 (1.0) 7.0 (2.1) 7.2 (1.5)
Cal intake (J) 12.461 (2.011) 11.032 (2.401) 12.796 (2.757) 12.654 (3.767)
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assigned to 2 groups: 10 subjects travelled to a 4-week altitude
training camp in South Africa (EXPMAX), and the remaining 19
subjects continued with their normal training programme at sea-
level (CONMAX). Each subject performed the test 3 weeks prior to
the altitude sojourn (PREMAX), after 19 days at altitude in the
EXPMAX group only (ALTMAX), and 10 and 20 days following
return to sea-level (POSTMAX1 and POSTMAX2, respectively).
Supramaximal measurements and procedures
Both studies incorporated a track test 3 weeks pre- and 3 weeks
post-altitude sojourn and between weeks 2 and 3 at the respec-
tive altitude training camps. Subjects were instructed to perform
four repetitions of 1000 m on a tartan track, separated by a 2-
min recovery walk at the fastest and most consistent velocity
possible.
Cardiorespiratory measurements
Flow loop spirometry (Cosmed Kit, Cosmed SRL, Rome, Italy)
was used for the determination of forced vital capacity, maximum
voluntary ventilation and mid-expiratory flow rates. Timed mea-
surements of expired air were analysed using an on-line gas analysis
system, (MedGraphics Cardiopulmonary Exercise Systems CPX/
D, Cardiokinetics, UK) which was validated with an o-line ref-
erence system. A bipolar three-lead electrocardiogram (ECG) was
displayed during exercise (Rigel 304, Graseby Medical, London).
Heart rates (HR) during the track sessions were recorded via ECG
calibrated bipolar telemetry (Vantage, Polar Electro, Oy, Finland).
Ratings of perceived exertion were also monitored during the ex-
ercise tests (Borg 1973).
Haematological measurements
Arterialised capillary blood samples (20 ll) were sampled from the
right earlobe for the subsequent determination of [La)]B using an
automated analyser (Analox PLM5 Champion, London, UK).
Serum urea was measured using a portable reflectance photometer
(Refletron, Manheim Boehringer, Germany). Venous blood sam-
ples were collected after a 12-h overnight fast and 48 h following
exercise by antecubital venupuncture, 30 min after the subject had
assumed a seated position to control for plasma volume shifts
(Pronk 1993). Blood samples were analysed for a full blood count,
serum ferritin, serum vitamin B12, red cell folate, plasma iron and
transferrin. Plasma was frozen and, following deproteinisation, was
subsequently analysed for glutamine via an enzymatic method
(Windmueller and Spaeth 1974). Briefly, glutamine was hydrolysed
with asparaginase to produce glutamate. This was hydrolysed to
a-ketoglutarate with glutamate dehydrogenase, and the rate of
oxidation (i.e. formation of NADH) was detected spectrophoto-
metrically at 340 nm (Gilford, Stasar III, UK).
Dietary analysis
All subjects completed a self-reporting 3-day dietary analysis 3
weeks prior to the altitude training camp, which was analysed using
a computer program (Compeat, UK).
Illness
Each subject in study 2 was issued with a 7-day questionnaire
prior to sea-level laboratory testing and on a daily basis during
the training period at altitude or at sea-level. Experience of gas-
trointestinal and/or upper respiratory tract infections, which in-
cluded persistent coughing, sore throat, cold/influenza, fever,
diarrhoea and vomiting were recorded on a daily basis by the
subjects.
Training programme
Subjects recorded total weekly running distances and their corre-
sponding HR 1 week prior to PRE and POST testing and during
weeks 1–4 at altitude. These distances were divided into track (HR
» 170–185 beats á min)1) and steady-state (HR » 140–160 beats á
min)1) running sessions. All subjects were instructed to continue
with their current training programme throughout the duration of
the study. The EXP groups performed altitude training sessions at
the same relative exercise intensity as the training conducted at sea-
level (i.e. same HR) with the use of ECG-calibrated bipolar te-
lemetry.
Statistical analyses
The mean sample size required for the detection of a statistically
significant dierence as a function of the treatment eect (hypo-
baric hypoxia) was determined for a variety of dependent variables,
according to Altman (1980). Data were analysed using both
parametric and non-parametric statistics following application of
the Shapiro-Wilk W test for Normality (Altman 1991) and the
Normal P-P Plot (Kinnear and Gray 1994). Within-group com-
parisons were analysed using a paired-samples t-test and a one-
factor repeated measures analysis of variance (ANOVA). The
Wilcoxon Matched-Pairs Signed-Ranks test and the Friedman test
served as the non-parametric equivalents. Between-group com-
parisons were conducted using a t-test for independent samples or
the Mann-Whitney U test. Statistical significance was defined at the
P < 0.05 level for all two-tailed tests, and values are reported as
means (SD).
Results
Resting haematologic and cardiorespiratory data
The confounding eects of hypohydration on the hae-
modynamic and cardiorespiratory responses to hypo-
baric hypoxia were minimal. Fluid intake at sea-level
and altitude ranged from 2.5 to 10.1 l á day)1 and, as a
consequence, the EXP group appeared to be in a euhy-
drated state. Resting urine osmolalities did not change
during study 2. Mean osmolalities at sea-level and alti-
tude ranged from 386 to 746 mosmol á kg)1 for the EXP
group and from 614 to 761 mosmol á kg)1 for the CON
group. Chronic hypobaric hypoxia had no eect on
resting Hb concentration, packed cell volume or resting
serum urea concentration (Tables 2 and 3). Haematinic
data remained stable throughout the South Africa study
(Table 4). Group mean serum ferritin concentrations
were low and four subjects in the EXP group and six
subjects in the CON group were iron deficient (serum
ferritin concentration <35 ng á ml)1) despite daily iron
supplementation. Resting HR decreased during and 10
days following the South Africa sojourn (P < 0.01 and
P < 0.05, respectively vs PRE). Mean arterial blood
pressure remained stable throughout the studies. Lung
function did not change at altitude despite a 20% re-
duction in air density.
The frequency of upper respiratory tract and/or
gastrointestinal tract infections increased markedly
during both altitude sojourns (Fig. 1). In contrast, there
were no reports of infectious illnesses for subjects in the
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CON group. A positive Paul-Bunnell blood test indi-
cated that two male subjects had contracted infectious
mononucleosis 14 days following their return to sea-level
(Bailey and Davies 1997). Whilst the EXP group mean
resting leucocyte and neutrophil counts increased after
19 days at altitude (P < 0.05 vs PRE) plasma glutamine
concentration decreased by 143 (74) lM (P < 0.001 vs
PRE). The greatest decrease in resting plasma glutamine
concentration was noted in two Commonwealth med-
allists who complained of fatigue and extreme tiredness
[)250 lM vs a group mean of )112 (40) lM].
Study 1: Submaximal test
The mean [La)]B concentration decreased by
0.63 mmol á l)1 (P < 0.05 vs PRE) for the EXP group
only following their return to sea-level (Table 5). Run-
Table 2 Resting cardiorespiratory and haematologic data at sea-
level and altitude. (PRE Pre-altitude test, ALT altitude test, POST
post-altitude test, EXPSUB experimental submaximal exercise
group, CONSUB control submaximal exercise group, Hb hae-
moglobin, PCV packed cell volume, HR heart rate, MABP mean
arterial blood pressure, FEF25–75%, mid-expiratory flow rate,MVV
maximal voluntary ventilation)
EXPSUB CONSUB
PRE ALTa POST PRE POST
Serum urea (mmol á l)1) 5.63 (1.79) 6.57 (1.26) 6.01 (1.56) 4.89 (1.26) 5.52 (1.90)
Hb (g á dl)1) 14.5 (1.7) 15.3 (1.2) 15.1 (1.5) 15.2 (1.3) 15.1 (1.3)
PCV (l á l)1) 0.44 (0.04) 0.45 (0.03) 0.45 (0.05) 0.47 (0.03) 0.46 (0.03)
Supine HR (beats á min)1) 41 (2) 42 (3) 41 (2) 43 (2) 42 (3)
MABP (mmHg) 91 (10) 85 (7) 88 (8) 96 (10) 90 (7)
FVC (l á min)1) 4.86 (1.06) 5.01 (1.02) 4.79 (1.13) 4.90 (0.77) 4.79 (0.77)
FEF25–75% (l á min
)1) 3.71 (0.89) 3.72 (0.92) 3.74 (1.04) 4.66 (1.04) 4.48 (0.93)
MVV (l á min)1) 159 (35) 172 (37) 158 (39) 180 (34) 185 (33)
aALT test which represents mean values obtained between days 8 and 19 at 1500–2000 m above sea-level
Table 3 Resting cardiorespiratory and haematologic data at sea-level and altitude. (POST1 Ten-days post-altitude test, POST2 20 days
post-altitude test, EXPMAX experimental maximal exercise group, CONMAX control maximal exercise group)
EXPMAX CONMAX
PRE ALTa POST1 POST2 PRE POST2
Serum urea (mmol á l)1) 4.59 (1.45) 5.48 (0.51) 5.67 (1.38) 4.97 (0.72) 5.65 (1.37) 6.12 (1.17)
Hb (g á dl)1) 15.0 (1.1) 15.7 (1.0) 16.3 (0.87) 15.7 (1.2) 15.0 (0.9) 15.0 (1.2)
PCV (l á l)1) 0.47 (0.04) 0.47 (0.03) 0.48 (0.02) 0.46 (0.03) 0.48 (0.03) 0.49 (0.03)
Supine HR (beats á min)1) 53 (6) 48 (4)** 49 (6)* 56 (6) 50 (5) 53 (8)
Urine osmolarity (mOsm) 386 (193) 598 (151) 746 (274) 580 (316) 761 (332) 614 (267)
MABP (mmHg) 88 (4) 79 (7) 79 (8) 84 (7) 87 (9) 88 (7)
FVC (l á min)1) 5.28 (0.95) 5.49 (0.86) 5.48 (0.61) 5.31 (0.92) 5.15 (0.71) 5.18 (0.71)
FEF25–75% (l á min
)1) 4.59 (1.36) 4.62 (1.41) 4.60 (1.25) 4.40 (1.41) 4.16 (1.12) 4.09 (1.10)
MVV (l á min)1) 179 (38) 193 (39) 187 (19) 176 (39) 156 (39) 165 (39)
*Dierent from within group PRE value, P < 0.05
**Dierent from within group PRE value, P < 0.01
aALT test which represents mean values obtained between days 15 and 27 at 1640 m above sea-level
Table 4 Haematinic data at sea-level. Reference values: iron, 9.0–
29.0 lmol á l)1; transferrin, 1.7–3.4 g á l)1; vitamin B12, 180–
1132 pg á ml)1; red cell folate, 125–600 lg á l)1; serum ferritin for
males, 20–300 ng á ml)1; serum ferritin for females, 10–
300 ng á ml)1. (PRE EXP Pre-altitude experimental group test,
POST2 EXP 20 days post-altitude experimental group test, PRE
CON pre-altitude control group test, POST2 CON 20 days post-
altitude control group test)
Timing/ Iron Transferrin Vitamin B12 Red cell Ferritin
Group (lmol á l)1) (g á l)1) (pg á ml)1) folate (lg á l)1) (ng á ml)1)
PRE EXP 22.8 (3.7) 2.9 (0.3) 574 (171) 436 (117) 48 (35)
POST2 EXP 24.5 (4.8) 2.9 (0.2) 495 (20) 372 (22) 46 (20)
PRE CON 26.4 (11.0) 3.3 (1.7) 956 (56) 491 (112) 42 (33)
POST2 CON 21.7 (7.7) 2.7 (0.4) 845 (126)* 343 (101)* 44 (27)
*Dierent from within group PRE value, P < 0.05
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ning velocity at 2 mmol á l)1 [La)]B and 4 mmol á l
)1
[La)]B increased by 9% (P < 0.05) and 12%
(P < 0.05), respectively in the EXP group, whilst no
changes were observed in CON group mean values.
However, the reduced lactic acidosis was not associated
with any significant changes in the h [La)]B value, thus it
was apparent that the exponential increase in [La)]B oc-
curred at the same absolute running velocity. Hypobaric
hypoxia did not aect the cardiorespiratory response to
submaximal exercise following return to sea-level.
Study 2: Maximal test
Table 6 demonstrates that the EXP group mean _V O2max
decreased by 13% after 20 days at altitude (P < 0.05 vs
PRE) and that arterial oxygen saturation decreased to
82 (5)% despite a 75.1 l á min)1 increase in minute
ventilation P < 0.01 vs PRE). Maximal HR and run-
ning time to exhaustion also decreased by 12 beats
min)1 (P < 0.01 vs PRE) and 122 s (P < 0.05 vs PRE),
respectively. There were no metabolic or cardiorespira-
tory changes observed following either 10 or 20 days
return to sea-level.
Supramaximal exercise performance
Ambient temperature, relative humidity and wind ve-
locity were comparable at sea-level and altitude. The
metabolic and cardiovascular responses observed during
and following recovery from supramaximal exercise
were not altered by chronic hypoxia (Tables 7 and 8).
However, mean running velocity decreased by 3% at
1,500 m and 4% at 1,640 m (P < 0.05 vs PRE) and
remained 0.13 m á s)1 slower following return to sea-
level in the altitude-trained group only (P < 0.05 vs
PRE).
Fig. 1 Pooled data represent-
ing the incidence of infectious
illness at sea-level and during
two altitude sojourns (1500–
1640 m). A1–A28 represent
days spent at 1500–1640 m.
Table 5 Metabolic and cardiorespiratory responses to a standar-
dised submaximal treadmill test. [[La)]B Whole blood lactate con-
centration; V2mmol á l)1, interpolated running velocity at
2 mmol á l)1 [La)]B,V4mmol á l)1 interpolated running velocity at
4 mmol á l)1 [La)]B, r
2 co-ecient of determination of exponential
equation during curve fitting procedure, h[La)]B lactate threshold
(according to the Dmax method of Cheng et al. 1992), RPE ratings
of perceived exertion, _V O2 oxygen uptake (STPD), _V E minute
ventilation (BTPS), _V E= _V O2, ventilatory equivalent for oxygen
(BTPS), respiratory exchange ratio (STPD)]
PRE EXPSUB POST EXPSUB PRE CONSUB POST CONSUB
[La)]B (mmol á l
)1) 2.69 (0.37) 2.06 (0.54)* 2.65 (0.24) 2.42 (0.37)
V2mmol á l)1a (m á s
)1) 4.64 (0.40) 5.04 (0.54)* 4.73 (0.38) 4.91 (0.42)
r2 value 0.83 0.79 0.79 0.79
V4mmol á 1)1 (m á s
)1) 5.97 (0.83) 6.70 (1.13)* 5.94 (0.81) 6.19 (0.96)
r2 value 0.83 0.79 0.79 0.79
h [La)]B (l á min
)1) 3.83 (0.65) 3.79 (0.57) 3.52 (0.57) 3.65 (0.61)
HR (beats á min)1) 161 (9) 160 (9) 165 (6) 165 (5)
RPE 13 (1) 12 (2) 13 (1) 13 (1)
_V O2 (l á min
)1) 3.74 (0.64) 3.69 (0.52) 3.47 (0.50) 3.50 (0.58)
_V E (l á min
)1) 101.6 (17.0) 97.6 (17.6) 93.6 (10.7) 97.9 (9.5)
_V E= _V O2 27.3 (2.2) 26.4 (2.7) 27.2 (1.6) 28.4 (2.9)
R 0.97 (0.04) 0.96 (0.02) 0.97 (0.02) 0.97 (0.03)
*Dierent from within group PRE value, P < 0.05
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Discussion
Immune function at altitude
Hypobaric hypoxia causes some adverse changes in
immune function, possibly due to the immunomodula-
tory roles of endogenous glucocorticoids and neuro-
peptides which increase at altitude (Meehan 1987). The
marked increase in the frequency of upper respiratory
and gastrointestinal tract infections observed during the
altitude sojourn suggest an association between hypob-
aric hypoxia and the depression of normal immunore-
activity. Whilst communal living may have contributed
to the higher incidence of infectious illness at altitude,
there were no reports of any physical symptoms for
subjects in the CON group, despite identical living and
training conditions. All subjects prepared their own food
at sea-level and at altitude using identical brands which
also suggests that the risk of pathogenic invasion due to
the ingestion of foreign foods was minimal. Of the
subjects who contracted an infectious illness, two males
were diagnosed with infectious mononucleosis on their
return to sea-level. The onset of physical symptoms that
are characteristic of the first 3–5 days of the prodrome
suggested that these subjects were exposed to the Ep-
stein-Barr virus during the initial stages of altitude
acclimatisation.
In light of the importance of glutamine as a substrate
for macrophages and lymphocytes, Newsholme et al.
(1985) suggested that a decrease in the concentration of
plasma glutamine below a physiological range would
impair defence mechanisms against opportunistic infec-
tions. Thus, the decrease in resting plasma glutamine
Table 6 Metabolic and cardiorespiratory responses during maximal exercise at sea-level and altitude
Group/Timing [La)]B
(mmol á l)1)
HR
(beats á min)1)
_V O2
(l á min)1)
_V E
(l á min)1)
Endurance
Time (s)
PRE EXPMAX 6.08 (1.84) 187 (8) 5.15 (0.95) 177.2 (25.3) 485 (23)
ALTa EXPMAX 5.55 (0.70) 175 (6)** 4.48 (0.53)* 252.3 (42.1)** 383 (37)*
POST1 EXPMAX 6.79 (0.39) 191 (7) 5.21 (0.67) 165.0 (31.5) 460 (19)
POST2 EXPMAX 7.24 (2.76) 190 (6) 5.10 (0.59) 174.6 (17.6) 475 (31)
PRE CONMAX 6.29 (0.95) 189 (12) 4.43 (0.95) 142.3 (26.5) 539 (105)
POST2CONMAX 6.99 (1.33) 184 (11) 4.43 (0.86) 147.8 (27.1) 501 (99)
*Dierent from within group PRE value, P < 0.05
**Dierent from within group PRE value, P < 0.01
aALT test which represents mean values obtained between days 19 and 20 at 1640 m above sea-level
Table 7 Physiological responses during supramaximal exercise
EXP CON
PRE ALTa POST PRE POST
[La)]B (mmol á l
)1) 7.05 (1.49) 6.57 (0.96) 6.82 (0.62) 6.58 (0.62) 5.99 (0.84)
Repetition HR (beats á min)1) 172 (5) 170 (7) 174 (3) 185 (3) 183 (1)
Recovery HR (beats á min)1) 166 (1) 165 (9) 166 (7) 181 (3) 174 (6)
RPE 16 (2) 17 (2) 16 (2) 15 (2) 15 (1)
Running velocity (m á s)1) 5.67 (0.50) 5.52 (0.51)* 5.69 (0.55) 5.62 (0.60) 5.62 (0.69)
*Dierent from within group PRE value, P < 0.05
aALT test conducted on day 16 at 1500 m above sea-level
Table 8 Physiological responses during supramaximal exercise
EXP CON
PRE ALTa POST PRE POST
[La)]B (mmol á l
)1) 7.93 (0.23) 7.19 (0.39) 7.73 (1.26) 7.02 (1.13) 7.91 (1.37)
Repetition HR (beats á min)1) 181 (10) 178 (6) 185 (8) 181 (10) 181 (10)
Recovery HR (beats á min)1) 138 (10) 134 (20) 138 (9) 127 (11) 129 (11)
RPE 14 (1) 17 (0) 16 (2) 14 (1) 15 (2)*
Running velocity (m á s)1) 5.79 (0.10) 5.55 (0.13)** 5.67 (0.09)* 5.63 (0.55) 5.63 (0.50)
*Dierent from within group PRE value, P < 0.05
**Dierent from within group PRE value, P < 0.01
aALT test conducted on day 18 at 1640 m above sea-level
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concentration observed on day 19 at altitude during this
study may have contributed to the apparent depression
of normal immune function. Glutamine uptake is re-
quired by the kidney to maintain acid-base balance
(Goldstein et al. 1980) and increased metabolic acidosis
mediated by hypoxia would increase the rate of gluta-
mine uptake. Hypoxia may increase the hepatic uptake
of glutamine which is a precursor for the production of
the antioxidant glutathione (Hong et al. 1992). Hypoxia
is associated with an increased production of free radi-
cals (Simon-Schnass 1994; Vasankari et al. 1997) and
thus the production of eective free radical scavengers
would prove beneficial. Finally, Wagenmakers (1992)
suggested that the hyperadrenalinaemia associated with
chronic hypoxia would result in a depletion of 2-oxo-
glutarate which is required for activation of the bran-
ched-chain amino acid aminotransferase reaction that
ultimately produces glutamine, and hyperadren-
alinaemia decreases the rate of glutamine transport out
of rat muscle incubated in vitro (Garber et al. 1976).
A modification of an idea by Rowbottom et al. (1996)
describes the relationship between ambient PO2, training
load (intensity and duration) and the subsequent risk of
infection (Fig. 2). Once a threshold training load is ex-
ceeded (depicted as the metabolic crossover point),
concentrations of glutamine would decrease below a
physiological range and the risk of infection would
subsequently increase. A decreased PIO2 may shift the
metabolic crossover point to the left, thus increasing the
aperture of the ‘‘window of opportunistic infection’’.
Glutamine supplementation at altitude may help to en-
hance immune function, since glutamine feeding de-
creases an athlete’s susceptibility to developing
respiratory infections at sea-level (Castell et al. 1996).
Altitude training and submaximal exercise performance
at sea-level
A decreased lactic acidosis was observed during sub-
maximal exercise at sea-level in the group that trained at
altitude. Similar findings have been reported at sea-level
following 3–10 weeks of training at an ambient PO2
ranging from 93 to 125 mmHg (Asano et al. 1986;
Terrados et al. 1988; Bender et al. 1989; Ingjer and
Myhre 1992). Bender et al. (1989) identified that a de-
crease in lactate flux from skeletal muscle to blood was
responsible for the decreased lactic acidosis observed in
subjects at sea-level following a 3-week exposure to
4,300 m. Several mechanisms may be implicated in the
modulation of glycolytic flux in hypoxia which include,
hypoxia-induced secondary polycythaemia and the at-
tendant increase in CaO2 (Berglund 1992), shifts in
substrate utilisation towards predominantly b-oxidation
of fatty acids (Beidleman et al. 1994), beneficial altera-
tions in the structural morphology and enzymatic
characteristics of skeletal muscle, capillary neoformation
(Desplanches et al. 1993), increase in intracellular buf-
fering capacity (Favier et al. 1995) and an ‘‘upstream’’
inhibition of glycolysis regulated by a decreased central
drive (Kayser et al. 1994) and/or changes in the b-ad-
renergic sensitivity of glycolysis (Brooks et al. 1992). The
decreased lactic acidosis appeared to be independent of
any apparent increases in CaO2 or fat oxidation, as
noted by a stable Hb concentration at rest and the re-
spiratory exchange ratio during exercise. However, the
fact that the h [La)]B and other cardiorespiratory de-
terminants of running economy were unchanged fol-
lowing return to sea-level questions the functional
significance of the decreased lactic acidosis.
Altitude training and maximal exercise performance
at sea-level
Chronic hypoxia did not influence performance either
during or following recovery from maximal exercise af-
ter 10 or 20 days return to sea-level. These findings are
consistent with the majority of controlled investigations
that have induced hypobaric or normobaric hypoxia
either as an intermittent (Hahn et al. 1992; Desplanches
et al. 1993; Favier et al. 1995) or continuous stimulus
Fig. 2 Hypothetical model de-
scribing the relationship be-
tween training load, ambient
partial pressure of oxygen
(PO2) and plasma glutamine
concentration (dashed line) and
risk of developing an infectious
illness (solid line). (X Metabolic
crossover point)
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(Svedenhag et al. 1991; Rusko et al. 1996; Telford et al.
1996).
The present hypoxic stimulus was not sucient to
increase blood reticulocyte count and subsequent Hb
concentration and, as a consequence, CaO2 most prob-
ably did not change. The prevalence of iron deficiency in
the EXP group despite daily enteral iron supplementa-
tion may have suppressed haematological adaptation.
Logistical limitations precluded the administration of
parenteral iron treatment prior to the altitude sojourn to
normalise subject iron stores. Iron demand and mobili-
sation increases markedly during hypoxia to support the
elevated reticulocytosis (Reynfarje et al. 1959) and thus
the already depleted iron stores at sea-level may have
proved insucient to meet the increased demand for Hb
synthesis at altitude.
Altitude training and supramaximal exercise
performance at sea-level
Whilst aerobic metabolism is the predominant means of
removing [La)]B and replenishing ATP and creatine
phosphate stores during recovery from supramaximal
exercise (> _V O2max), the provision of energy during the
1000-m track repetitions would require a significant
contribution from anaerobic metabolism. Chronic ex-
posure to environmental hypoxia improves anaerobic
metabolism, due predominantly to an increase in muscle
buer capacity and the associated improvements in acid-
base status (Mizuno et al. 1990; Svedenhag et al. 1991;
Favier et al. 1995; Nummella et al. 1996). Elevated
muscle lactate and H+ concentration, in addition to a
compensatory respiratory alkalosis during the early
stages of altitude acclimatisation result in a greater de-
crease in pH per mmol H+ release (West 1986). The
increased buer capacity at altitude may therefore serve
as an adaptive mechanism which attenuates the degree
of acidosis (Svedenhag et al. 1991).
Chronic exposure to hypobaric hypoxia impaired
supramaximal exercise performance 20 days following
return to sea-level. Group mean running velocity de-
creased by 2% in the altitude-trained group. This re-
sponse appeared to be independent of any changes in
training load, environmental conditions and subject
motivation. A decrease in absolute training intensity
due to an alveolar-end-capillary diusion limitation
and/or the performance debilitating eects of subclini-
cal infections mediated by the immunosuppressive ef-
fects of hypoxia may have been implicated in this
response.
Conclusion
Two investigations demonstrated that 4 weeks of mod-
erate altitude training at 1500–2000 m did not improve
performance during and following recovery from either
submaximal or maximal exercise. Chronic hypoxia im-
paired supramaximal exercise performance following
return to sea-level. A decrease in absolute training in-
tensity at altitude and a marked increase in the incidence
of infectious illness, possibly due to a decrease in resting
plasma glutamine concentration, may be implicated in
these responses.
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